Decreased levels of low-density lipoprotein cholesterol (LDL-C) in the use of low and moderate-intensity statin in type2 diabetic patients treated in community hospital.
Completed
- Conditions
- The reduction of LDL-C levels of low and moderate intensity statin drugs in type 2 diabetic patients in community hospitalstatins, intensity, LDL, diabetes mellitus
- Registration Number
- TCTR20230101001
- Lead Sponsor
- /A
- Brief Summary
ow intensity statin can reduce LDL-C in type2 diabetic patients more than 30%, which is greater than the average percentage of LDL-C reductions according to the statin intensity according to 2013 ACC/AHA guideline. Moderately intensity statin was not different (30-50%).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 71
Inclusion Criteria
1.Type 2 diabetic patient in Bangbo hospital
2. Age > 15 year olds
3.LDL-C before treatment > 100 mg/dl
4. Treatment of hyperlipidemia with simvastatin (10, 20, 40 mg ) or atorvastatin 20 mg
5. Received at least 3 months of treatment, and LDL-C levels were monitored before and at least 3 months after dosing
Exclusion Criteria
1. Patients without LDL-C testing before and after drug administration
2. Patients were previously treated with statins elsewhere.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reduction of LDL-C levels 3 months LDL-C levels
- Secondary Outcome Measures
Name Time Method n/a n/a n/a